News

Lurasidone in a Patient with Paranoid Schizophrenia and Asperger's Syndrome – A Case Study
Lurasidone is an effective and very gentle antipsychotic which is establishing a prominent position in modern psychopharmacotherapy. Its unique receptor profile makes it a suitable choice for hyperprolactinemia induced by risperidone. A significant benefit of lurasidone is its favorable cardiometabolic profile. Switching from another antipsychotic to lurasidone can be performed on an outpatient basis. Most importantly, it is essential to highlight its effect on both positive and negative symptoms of schizophrenia, as demonstrated by the…

Clinical Significance of Smaller Gaps Between Strengths of Levothyroxine Preparations in the Treatment of Hypothyroidism

Generic Substitution of Levothyroxine in Practice

Options for Systemic Therapy of Advanced Stage Small Cell Lung Cancer

Current Sequence of Treatment for Metastatic HER2+ Breast Cancer

Artificial Intelligence and Deep Learning as the Future of Glaucoma Diagnosis

MUDr. Jana Zárubová: Experiences with buccal midazolam in real practice are positive and we can significantly improve patients' quality of life

IEC 2023: Key Challenges for Epilepsy Patients Include Status Epilepticus and Anxiety Management

Ocrelizumab in the Treatment of Multiple Sclerosis – 10-Year Data

Long-term Efficacy and Safety of Mavacamten in the Treatment of Obstructive HCM
Conferences
News from the world of medicine
All conferences
Popular this week
- How Do Chronic and Acute Stress Affect the Gastrointestinal Tract?
- AI Could Transform Cancer Treatment by Precisely Identifying Tumor Cells
- “Clinical Bites” – Research Highlights 2025/28
- Why Do We Forget About the Nocebo Effect, Even Though It Is Stronger Than the Placebo Effect?
- Europe Reads DNA: Genomic Projects Shaping the Future